A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Clinical trial NCT03451851 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03451851
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-11
- Primary completion
- 2023-07-19
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.